Breadcrumb
Presentation Materials
Phase I characterization of the novel cathepsin C inhibitor BI 1291583
Material Type: Poster
Phase II study design of a novel cathepsin C inhibitor BI 1291583 in patients with bronchiectasis (AirleafTM)
In vitro and in vivo characteristics of the novel cathepsin C inhibitor BI 1291583 for use in bronchiectasis
Clarifying the pathway to an accurate diagnosis of interstitial lung disease: results from a modified Delphi survey in the USA
A multivariable protein-inclusive predictor of death or lung transplant in patients with idiopathic pulmonary fibrosis
Deep learning improves sensitivity of UIP classification on CT
